Research
Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports
Emma Maund, Louise Schow Guski and Peter C. Gøtzsche
CMAJ February 06, 2017 189 (5) E194-E203; DOI: https://doi.org/10.1503/cmaj.151104
Emma Maund
Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
MSc PhDLouise Schow Guski
Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
MDPeter C. Gøtzsche
Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
MDData supplements
Related Articles
- Braillon, A. (2017). Duloxetine: urinary incontinence and marketing authorization incontinence. CMAJ, 189(9), E373. Accessed August 14, 2024. https://doi.org/10.1503/cmaj.732561.
In this issue
Article tools
Respond to this article
Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports
Emma Maund, Louise Schow Guski, Peter C. Gøtzsche
CMAJ Feb 2017, 189 (5) E194-E203; DOI: 10.1503/cmaj.151104